ENTERO HEALTHCARE SOLU L Share Price

ENTERO HEALTHCARE SOLU L Share Price

NSE: ENTERO
|
Trading
|
S Cap
₹ 1,848.00
+₹50.60 (2.82%)
1D
Last updated 03 Sep, 2026, 15:57 IST

ENTERO HEALTHCARE SOLU L Share Price Today

As of 4 Sep 2026, ENTERO HEALTHCARE SOLU L share price is ₹1,848.00. The stock opened at ₹1,810.00, compared to its previous close of ₹1,797.40. During today's trading session, ENTERO HEALTHCARE SOLU L share price moved in the range of ₹1,795.20 to ₹1,863.00, with an average price of ₹1,829.10 for the day. Looking at its last 52-week, the stock has touched a low of ₹944.00 and a high of ₹1,863.00.

₹1,795.20
2.82% up today
₹1,863.00
1D LOW
1D HIGH

ENTERO HEALTHCARE SOLU L Returns Calculator

Circuit
L
H
₹1,438.00
₹2,156.80
52-week
L
H
₹944.00
₹1,863.00

About ENTERO HEALTHCARE SOLU L

ENTERO HEALTHCARE SOLU L Share Price
ISIN
INE010601016
Sector Market Cap
₹ 7,832.85 Cr

Entero Healthcare Solutions Limited is an India-based technology-driven and integrated healthcare products distribution company. It offers a range of pharmaceuticals and other healthcare products to approximately 86,200 retail pharmacies and healthcare practitioners (HCPs) across 492 districts in India. Its portfolio includes over 68,900 SKUs from more than 2000 pharma companies. The Company is a supplier to over 3,500 hospitals across India, including corporate hospital chains. It has over a network of 104 warehouses. Its technology solutions include Entero Direct, Entero CRM, Entero ERP, and Teqtic. Its Entero Direct platform is a cloud-based software-as-a-service solution that allows retailers to order their procurement needs. The Entero CRM application is a customer relationship management tool that manages and analyzes its interactions with customers, in order to customer retention and wallet share. It also offers its products through the Aayu Chemist app and Medcords platform.

ENTERO HEALTHCARE SOLU L Financial Highlights

  • Revenue: ENTERO HEALTHCARE SOLU L reported revenue of ₹6,610.45 crore in FY26 vs ₹5,135.29 crore in FY25. It showed an increase of 28.73% on a yearly basis.
  • Operating Profit: ENTERO HEALTHCARE SOLU L reported an operating profit of ₹179.34 crore in FY26 vs ₹138.74 crore in FY25. It showed an increase of 29.26% on a year-on-year basis.
  • Net Profit: ENTERO HEALTHCARE SOLU L reported a net profit of ₹145.84 crore in FY26 vs ₹107.43 crore in FY25. It showed an increase of 35.75% on a yearly basis.

ENTERO HEALTHCARE SOLU L Quarterly Result Highlights

  • ENTERO HEALTHCARE SOLU L reported revenue of ₹1,943.51 crore in Jun 2026, compared with ₹1,913.94 crore in Mar 2026, representing an increase of 1.54% on a quarter-on-quarter (QoQ) basis.
  • ENTERO HEALTHCARE SOLU L reported an operating profit of ₹67.12 crore in Jun 2026, compared with ₹57.95 crore in Mar 2026, representing an increase of 15.82% on a quarter-on-quarter (QoQ) basis.
  • ENTERO HEALTHCARE SOLU L reported a profit of ₹52.05 crore in Jun 2026, compared with ₹45.13 crore in Mar 2026, reflecting an increase of 15.33% on a QoQ basis.
  • The earnings per share (EPS) of ENTERO HEALTHCARE SOLU L stood at ₹26.44 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
52.40%
FII
4.37%
Other DII
6.51%
Retail and other
27.75%
Mutual funds
8.97%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 202514.67%
Dec 20255.14%
Mar 20264.03%
Jun 20264.37%
Mkt Cap Cr
7,832.85
P/E
46.72
P/B
4.66
ROE
6.81%
D/E
0.08
ROCE
9.74%
Div. Yield
0.00%
EPS(TTM)
6.18
Turnover
0.16
EV/EBITDA
26.07
Net Margin
8.38%
Op. Margin
14.30%
ROA
4.66%
Quick Ratio
2.04
Curr. Ratio
2.43
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Entero Healthcar outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Entero Healthcar appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Entero Healthcar revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,791.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,45,081.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,90,351.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,14,833.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,163.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,431.0017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Mankind Pharma98,304.7047.546.0311.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma95,299.8025.682.529.25%0.1911.76%394.820.24%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

ENTERO HEALTHCARE SOLU L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹6,591.21₹5,095.78₹3,922.31₹3,300.21
Other Income₹19.24₹39.51₹14.41₹5.51
Total Revenue₹6,610.45₹5,135.29₹3,936.72₹3,305.72
Total Expenses₹6,422.94₹4,996.55₹3,901.17₹3,309.41
Profit Before Tax₹179.34₹138.74₹35.56-₹3.69
Tax₹33.50₹31.31-₹4.24₹7.42
Profit After Tax₹145.84₹107.43₹39.80-₹11.10
EPS - Basic₹26.44₹21.80₹10.81-₹0.18
EPS - Diluted₹26.40₹21.76₹10.81-₹0.18

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹179.34₹138.74₹35.56-₹3.69
Income before WC changes₹286.43₹182.79₹122.17₹67.47
Change in Assets-₹151.31-₹299.88-₹142.49-₹152.98
Change in Liabilities₹14.83₹78.36-₹3.24₹52.62
Change in WC-₹136.48-₹221.52-₹145.73-₹100.36
Cash flow from Operations₹96.20-₹76.87-₹36.61-₹45.32
Cash flow from Investing-₹303.06₹219.80-₹705.12-₹48.60
Cash flow from Financing₹123.66-₹73.66₹862.94₹72.76
Total Cash Flow-₹83.20₹69.27₹121.21-₹21.15
Cash (Start of the year)₹229.28₹147.65₹25.36₹46.51
Cash (End of the year)₹146.88₹229.28₹147.65₹25.36

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,091.83₹626.81₹334.00₹285.56
Current Assets₹2,508.44₹2,075.71₹2,010.98₹1,023.17
Total Assets₹3,600.26₹2,702.52₹2,344.98₹1,308.73
Current Liabilities₹1,587.57₹845.02₹601.94₹623.96
Net Current Asset₹920.87₹1,230.69₹1,409.03₹399.21
Non-Current Liabilities₹260.15₹87.14₹101.65₹87.11
Equity Capital₹1,752.55₹1,770.36₹1,641.38₹597.66
Total Equity & Liabilities₹3,600.26₹2,702.52₹2,344.98₹1,308.73

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹348.24₹408.67₹318.16₹177.69
Other Income₹113.72₹114.37₹89.93₹52.57
Total Revenue₹461.96₹523.04₹408.09₹230.26
Total Expenses₹427.28₹449.18₹383.72₹242.71
Profit Before Tax₹30.19₹26.78₹24.37-₹12.46
Tax₹3.31₹7.60-₹14.08₹0.00
Profit After Tax₹26.88₹19.18₹38.44-₹12.46
EPS - Basic₹6.18₹4.41₹10.63-₹0.19
EPS - Diluted₹6.17₹4.40₹10.63-₹0.19

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹30.19₹26.78₹24.37-₹12.46
Income before WC changes-₹49.65-₹18.05-₹14.07-₹41.97
Change in Assets₹0.85-₹104.65-₹75.26-₹33.39
Change in Liabilities-₹7.02₹30.34₹15.47₹20.98
Change in WC-₹6.17-₹74.31-₹59.79-₹12.41
Cash flow from Operations-₹59.72-₹109.02-₹75.65-₹56.91
Cash flow from Investing-₹132.28₹207.75-₹762.69-₹58.29
Cash flow from Financing₹97.58-₹40.89₹925.56₹91.11
Total Cash Flow-₹94.42₹57.84₹87.22-₹24.09
Cash (Start of the year)₹151.18₹93.34₹6.12₹30.20
Cash (End of the year)₹56.76₹151.18₹93.34₹6.12

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,428.76₹994.07₹107.60₹90.56
Current Assets₹728.90₹809.46₹1,660.99₹673.00
Total Assets₹2,157.66₹1,803.53₹1,768.58₹763.57
Current Liabilities₹321.87₹129.93₹127.82₹134.60
Net Current Asset₹407.03₹679.53₹1,533.16₹538.40
Non-Current Liabilities₹152.75₹23.22₹14.35₹45.23
Equity Capital₹1,683.04₹1,650.38₹1,626.41₹583.73
Total Equity & Liabilities₹2,157.66₹1,803.53₹1,768.58₹763.57
* All values are in INR Crore
Qty
Bid
107
1848
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 107
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
4
Neutral
2
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
85.71
Bullish
ATR (14)
75.81
Neutral
STOCH(9,6)
96.67
Bearish
STOCH RSI (14)
97.5
Bearish
ADX(9)
73.75
Bearish
UO(9)
63.73
Neutral
ROC(12)
31.23
Bullish
WillR(14)
-3.11
Bearish
Period
Simple value
Exponential vaue
5D
1813.78
1794.25
10D
1705.68
1713.95
20D
1546.59
1589.71
50D
1349.25
1416
100D
1273.05
1307.98
Volume trend — traded volume by day
3 Sep1L
2 Sep1L
1 Sep1L
31 Aug6L
28 Aug8L
Average3L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
ENTERO HEALTHCARE SOLU L Share Price
ENTERO HEALTHCARE SOLU L
Trading
Add Stock
Add Another

ENTERO HEALTHCARE SOLU L Share Price FAQs

ENTERO HEALTHCARE SOLU L share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837